|
Deadline extended for filing responses in anti-dumping probe on PNT imports from EU
|
|
Shardul Nautiyal, Mumbai
August 14 , 2025
|
|
|
The Directorate General of Trade Remedies (DGTR), under the Ministry of Commerce & Industry, has extended the deadline for stakeholders to submit their questionnaire responses in the ongoing anti-dumping investigation concerning imports of para-nitrotoluene (PNT) from the European Union (EU). The new deadline is now August 17, 2025.
PNT is a crucial intermediate in the pharmaceutical industry, primarily used in the synthesis of various active pharmaceutical ingredients (APIs) and pharmaceutical formulations. It is particularly valuable in producing drugs like benzocaine, procaine, para-aminobenzoic acid (PABA), and others.
The extension follows requests from several interested parties, including producers, exporters, importers, and users, who sought additional time to compile and file their submissions.
DGTR has urged stakeholders to submit complete and accurate responses by the revised deadline of August 17, 2025, as no additional time will be allotted beyond this date.
The probe, initiated through a notification dated June 16, 2025, stems from an application filed by Aarti Industries Limited, alleging that dumped imports of PNT from the EU are causing material injury to India’s domestic industry.
The applicant claims that domestic prices have been severely affected due to the influx of cheaper imports, leading to financial losses, cash flow issues, and negative returns on capital employed.
The applicant has submitted that there are no significant differences in the product produced by the applicant and exported from the subject country and both are like articles. The product produced by the applicant and imported from the subject country are comparable in terms of essential product characteristics such as physical and chemical characteristics, manufacturing process & technology, functions & usage, product specifications, pricing, distribution & marketing and tariff classification of the goods.
Consumers can use and have been using the two interchangeably. The two are technically and commercially substitutable, and hence, the product produced by the applicant should be treated as 'like article' to the imported product under the Rules. Thus, for the purposes of initiation of the present investigation, the product produced by the applicant has been prima facie considered as like article to the product being imported from the subject country.
The application has been filed by Aarti Industries Limited. There is another producer in India by the name Deepak Nitrite Limited. As per the information available on record, it is noted that the applicant has not imported the product under consideration from the subject country and is not related to any exporters in the subject country nor to any importers in India.
As per the information available on record, it is further noted that the production of the applicant represents a major proportion of domestic production and therefore constitutes 'domestic industry ' within the meaning of Rule 2(b) of the Rules and the application satisfies the criteria of standing in terms of Rule 5(3) of the Rules.
The investigation aims to assess whether imports of PNT from the EU are being dumped in the Indian market and, if so, to determine the degree of dumping and the appropriate anti-dumping duty necessary to protect the domestic industry.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|